AMHCU
Amplitude Healthcare Acquisition Corporation [AMHCU] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
AMHCU Stock Summary
In the News
AMHCU Financial details
Company Rating
Buy
Market Cap
0
Income
1.13M
Revenue
0
Book val./share
34.52
Cash/share
0.12
Dividend
-
Dividend %
-
Employees
1
Optionable
No
Shortable
Yes
Earnings
-
P/E
-173184.06
Forward P/E
-
PEG
-
P/S
-
P/B
1049.32
P/C
91.33
P/FCF
-1744.76
Quick Ratio
375.24
Current Ratio
3.42
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.54
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-165%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
0.02%
Inst Trans
6.6%
ROA
-1%
ROE
-1%
ROC
-0.01%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
10.96-12.2882
52W High
-8.67%
52W Low
+9.6%
RSI
-
Rel Volume
3.54
Avg Volume
1.19K
Volume
4.23K
Perf Week
0%
Perf Month
0%
Perf Quarter
-
Perf Half Y
0%
-
-
-
-
Beta
-
-
-
Volatility
0%, 0%
Prev Close
0%
Price
10.96
Change
0%
AMHCU Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2020-12-31
| Metric | History | 2020-12-31 |
|---|---|---|
| 2.02K | ||
| Revenue per share | 0 | |
| Net income per share | -0.05 | |
| Operating cash flow per share | -0.05 | |
| Free cash flow per share | -0.05 | |
| Cash per share | 8.09 | |
| Book value per share | 7.8 | |
| Tangible book value per share | 7.8 | |
| Share holders equity per share | 7.8 | |
| Interest debt per share | 0 | |
| Market cap | 125.13M | |
| Enterprise value | 124.35M | |
| P/E ratio | -211.82 | |
| Price to sales ratio | 0 | |
| POCF ratio | -195.21 | |
| PFCF ratio | -195.21 | |
| P/B Ratio | 1.28 | |
| PTB ratio | 1.28 | |
| EV to sales | 0 | |
| Enterprise value over EBITDA | -225.18 | |
| EV to operating cash flow | -194.01 | |
| EV to free cash flow | -194.01 | |
| Earnings yield | 0 | |
| Free cash flow yield | -0.01 | |
| Debt to equity | 0 | |
| Debt to assets | 0 | |
| Net debt to EBITDA | 1.39 | |
| Current ratio | 3.42 | |
| Interest coverage | 0 | |
| Income quality | 1.09 | |
| Dividend Yield | 0 | |
| Payout ratio | 0 | |
| Sales general and administrative to revenue | 0 | |
| Research and developement to revenue | 0 | |
| Intangibles to total assets | 0 | |
| Capex to operating cash flow | 0 | |
| Capex to revenue | 0 | |
| Capex to depreciation | 0 | |
| Stock based compensation to revenue | 0 | |
| Graham number | 2.88 | |
| ROIC | -0.01 | |
| Return on tangible assets | -0.01 | |
| Graham Net | 7.79 | |
| Working capital | 652.19K | |
| Tangible asset value | 97.49M | |
| Net current asset value | -2.85M | |
| Invested capital | 0 | |
| Average receivables | 0 | |
| Average payables | 0 | |
| Average inventory | 0 | |
| Days sales outstanding | 0 | |
| Days payables outstanding | 0 | |
| Days of inventory on hand | 0 | |
| Receivables turnover | 0 | |
| Payables turnover | 0 | |
| Inventory turnover | 0 | |
| ROE | -0.01 | |
| Capex per share | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2021-06-30 for Q2
| Metric | History | 2020-03-31 | 2020-06-30 | 2020-12-31 | 2021-03-31 | 2021-06-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 0 | 0 | 0 | |
| Net income per share | 0 | -0.02 | -0.21 | 2.2 | -1.43 | |
| Operating cash flow per share | -0.02 | -0.01 | 0 | -0.13 | -0.14 | |
| Free cash flow per share | -0.02 | -0.01 | 0 | -0.13 | -0.14 | |
| Cash per share | 0.08 | 0.07 | 40.44 | 0.24 | 0.12 | |
| Book value per share | 7.85 | 7.83 | 39 | 35.94 | 34.52 | |
| Tangible book value per share | 7.85 | 7.83 | 39 | 35.94 | 34.52 | |
| Share holders equity per share | 7.85 | 7.83 | 39 | 35.94 | 34.52 | |
| Interest debt per share | 0.03 | 0 | 0 | 0 | 0 | |
| Market cap | 118.75M | 128.13M | 25.03M | 24.75M | 24.85M | |
| Enterprise value | 117.69M | 127.21M | 24.25M | 24.16M | 24.54M | |
| P/E ratio | 763.96 | -113.56 | -12.18 | 1.13 | -1.74 | |
| Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
| POCF ratio | -509.94 | -736.99 | -4.67K | -77.89 | -68.86 | |
| PFCF ratio | -509.94 | -736.99 | -4.67K | -77.89 | -68.86 | |
| P/B Ratio | 1.21 | 1.31 | 0.26 | 0.28 | 0.29 | |
| PTB ratio | 1.21 | 1.31 | 0.26 | 0.28 | 0.29 | |
| EV to sales | 0 | 0 | 0 | 0 | 0 | |
| Enterprise value over EBITDA | 278.87 | -532.37 | -43.92 | 4.39 | -6.87 | |
| EV to operating cash flow | -505.4 | -731.73 | -4.52K | -76.03 | -68 | |
| EV to free cash flow | -505.4 | -731.73 | -4.52K | -76.03 | -68 | |
| Earnings yield | 0 | 0 | -0.02 | 0.22 | -0.14 | |
| Free cash flow yield | 0 | 0 | 0 | -0.01 | -0.01 | |
| Debt to equity | 0 | 0 | 0 | 0 | 0 | |
| Debt to assets | 0 | 0 | 0 | 0 | 0 | |
| Net debt to EBITDA | -2.51 | 3.83 | 1.39 | -0.11 | 0.09 | |
| Current ratio | 8.13 | 4.57 | 3.42 | 4.19 | 1.29 | |
| Interest coverage | -0.7 | -7.39 | 0 | 0 | 0 | |
| Income quality | -5.99 | 0.62 | 0.01 | -0.06 | 0.1 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0.74 | 1.99 | 13.43 | 42.17 | 33.3 | |
| ROIC | 0 | 0 | -0.01 | 0 | -0.01 | |
| Return on tangible assets | 0 | 0 | -0.01 | 0.05 | -0.04 | |
| Graham Net | -0.21 | -0.23 | 38.94 | -4.2 | -5.58 | |
| Working capital | 1.22M | 923.06K | 652.19K | 576.03K | 94K | |
| Tangible asset value | 98.12M | 97.84M | 97.49M | 89.86M | 86.29M | |
| Net current asset value | -2.28M | -2.58M | -2.85M | -10.34M | -13.84M | |
| Invested capital | 0 | 0 | 0 | 0 | 0 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 0 | 0 | 90.38K | 254.85K | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | 0 | 0 | -0.01 | 0.06 | -0.04 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
AMHCU Frequently Asked Questions
What is Amplitude Healthcare Acquisition Corporation stock symbol ?
Amplitude Healthcare Acquisition Corporation is a US stock , located in New york of Ny and trading under the symbol AMHCU
What is Amplitude Healthcare Acquisition Corporation stock quote today ?
Amplitude Healthcare Acquisition Corporation stock price is $10.96 today.
Is Amplitude Healthcare Acquisition Corporation stock public?
Yes, Amplitude Healthcare Acquisition Corporation is a publicly traded company.
Company Profile
- Volume Average 1.19K
- Employee 1
- CEO Mr. Balaji Venkataraman
- Headquarters New York,NY,US
- IPO Date 2019-11-20
-
Website
http://www.amplitudehealthcare.com 
Amplitude Healthcare Acquisition Corporation does not have significant operations. It intends to acquire assets and businesses through a merger, share exchange, share purchase, reorganization, or similar business combination with one or more businesses in the healthcare or healthcare related industries. The company was founded in 2019 and is based in New York, New York.
